You are here

TGA Internet site archive

The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.

CMEC Meeting 47, 13 August 2004

Complementary Medicines Evaluation Committee

13 August 2004

Extracted ratified minutes

How to access a pdf document

CMEC Meeting 47 extracted ratified minutes (pdf,76kb)

Public recommendation summary

This summary has been posted immediately after the CMEC meeting to give quick advice of the recommendations made by CMEC to the TGA. This summary does not represent the decisions of TGA. Reasons underlying these recommendations will be available after Members ratify the Minutes at the next CMEC meeting.

Item 2 Minutes of CMEC's 46th meeting

Recommendation 47.1

CMEC confirms that the draft Minutes of its previous meeting (CMEC 46, 11 June 2004), as amended, are a true and accurate record of that previous meeting.

Item 6.1 Application for the evaluation of a new substance - Digestive enzymes: amylase, tilactase, protease derived from Aspergillus oryzae; cellulase derived from Trichoderma longibrachiatum; and lipase derived from Rhizopus oryzae

Recommendation 47.5

CMEC recommends to the TGA that the following enzymes:

  • amylase, tilactase, protease derived from Aspergillus oryzae;
  • cellulase derived from Trichoderma longibrachiatum;
  • and lipase derived from Rhizopus oryzae

are suitable for use as active ingredients in Listed medicines.

Item 10.6 Matters referred from within TGA: Curcumin

Recommendation 47.8

CMEC notes the proposal by the Office of Complementary Medicines to permit the use of curcumin as an active ingredient in Listed medicines.

Top of page